This also suggests that the location (tumor biopsy in Figure 4 vs global NOD2 deficiency in mice) and timing of NOD2 signaling (NOD2 expression in established tumor vs NOD2 deficiency initiated by lysozyme expression) may have very different consequences on the immune response / tolerance balance. This evidence concerns the gene NOD2 and neoplasm.